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Background: It is unclear whether annual multidisciplinary reviews in cystic ﬁbrosis (CF) patients should be conducted in dedicated annual review
(AR) clinics or during continuous assessments throughout the year. Our aim was to assess the effect of introducing an AR clinic.
Methods: A retrospective written and electronic record review of CF patients was carried out for 2007 (no AR Clinic) and 2010 (established AR
Clinic) calendar years. An internet-based satisfaction survey was distributed to families attending the AR clinic.
Results: In total, 123 children (mean age 9.5 years, range 1.32–18.8 years) and 141 children (8.3 years, 1.1–18.3 years) were included in 2007 and
2010 respectively. There was a signiﬁcant increase in multidisciplinary reviews (documented annual review 28% vs 85%, P b 0.001; dietary
assessment 46% vs 92%, P b 0.001) and investigations (OGTT 2% vs 74%, P b 0.001; abdominal ultrasound 35% vs 85%, P b 0.001) conducted
after the introduction of AR clinic. The majority of the families surveyed (85%) were satisﬁed or very satisﬁed with the AR clinic.
Conclusions: CF AR clinic signiﬁcantly improves the number of annual investigations and multidisciplinary reviews performed. Families were
satisﬁed with this new process.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; Parental satisfaction; Quality improvement; Delivery of care; Chronic disease management1. Introduction
Annual reviews are embedded in routine cystic fibrosis (CF)
patient care today and recommended in all international CF
expert guidelines despite the lack of evidence of benefit [1–3].Abbreviations: AR, annual review; BAL, bronchoalveolar lavage; CA, con-
tinuous assessment; CF, cystic fibrosis; CXR, chest X-ray; IgE, immunoglobulin E;
NS, not significant; OGTT, oral glucose tolerance test; US, ultrasound
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http://dx.doi.org/10.1016/j.jcf.2013.09.001An unanswered question is whether annual review is best con-
ducted as continuous assessment throughout the year during
regular quarterly visits, or as dedicated formal Annual Review
(AR) Clinic visits once a year. To date, there have only been two
articles written on this topic [4,5]. None of these studies formally
assessed the changes before and after the introduction of a
dedicated AR clinic. In UK, 63% of the specialist CF centres
conduct a dedicated AR Clinic [6]. In Australia, only 19% of the
CF centres have a dedicated AR clinic (own unpublished data).
Less than half of the Australian centres (42.9%) are able to have
each patient reviewed by the whole CF multidisciplinary team
during annual reviews. At Sydney Children's Hospital (SCH), a
tertiary referral and teaching hospital in Australia, a dedicated AR
Clinic was established in 2008 whereby CF children attended this
clinic in place of one of their usual 3-monthly appointments, as
part a quality improvement initiative. The aim of this study was toby Elsevier B.V. All rights reserved.
Table 1
Annual review procedures.
≤5 y.o Over 5 y.o ≥10 y.o
Multidisciplinary team review— medical, nursing, dietetics, physiotherapy,
and social worker/psychologist.
Surveillance bronchoscopy
and BAL
Spirometry
Complex lung function if N8 y.o.
(plethysmography, lung clearance index)
Bloods— include liver
function tests, vitamin
levels
Bloods— same as
≤5 y.o, with the
addition of Aspergillus
status and total IgE level
Bloods— same as
N5 y.o, with the
addition of OGTT
CXR Abdominal US, CXR,
bone age X-ray
Abdominal US, CXR,
bone age X-ray, bone
densitometry scan.
BAL— bronchoalveolar lavage.
CXR— chest X-ray.
IgE— Immunoglobulin E level.
OGTT— oral glucose tolerance test.
US— ultrasound.
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multidisciplinary reviews and investigations completed.
2. Patients and methods
2.1. Continuous assessment procedures
Prior to 2008, each CF patient had their annual review assess-
ment during a routine CF clinic around the time of their birthday.
The CF clinic coordinator placed the annual review assessment
form in the patient's file for the physician and allied health
professionals to complete during the routine visit. The physician
completed the necessary request forms for the annual investiga-
tions which were given to the parents. The investigations were
either conducted on the day of the clinic or on another day, subject
to availability. Children under 5 had their annual surveillance
bronchoscopy arranged during this routine clinic assessment, and
returned on another day for the procedure together with the annual
blood tests under general anaesthesia.
2.2. Annual review clinic procedures
The CF AR Clinic was introduced at SCH at the end of 2008
as a quality improvement initiative because many members of
the multidisciplinary CF team were not able to review all
patients annually due to time constraints in a routine CF clinic.
A half–day dedicated AR clinic was established in the out-
patient department on a separate day from the routine CF clinic.
The CF clinic coordinator coordinates the scheduling of the clinic
review and the various investigations around the time of the
patients' birthday. All the information and instructions regarding
the clinic review, including time of radiological investigations,
fasting instructions, food and enzyme diary are mailed to
the family approximately 6 weeks before the scheduled AR clinic
review. The child and their family spend time with each of
the multidisciplinary CF team members, including a doctor,
nurse, dietician, physiotherapist, and social worker/psychologist
(Table 1). Children over 5 years have all the annual investigations
performed on the AR clinic day. Children under 5 have their
annual surveillance bronchoscopy and blood tests under anaes-
thesia on a separate day. Results from the preliminary investiga-
tions (such as lung function and available blood test results) and
clinical status are discussed at a CF team meeting the following
day. A formal annual review form is completed which includes a
report from all members of the multidisciplinary team and all
results of investigations. These findings are discussed with the
child and family in a routine CF clinic approximately 1 month
after the annual review. A typed formal annual report is given to
the family and distributed to any doctor associated with the care of
the patient.
2.3. Data collection
A retrospective review of written and electronic medical
records of CF patients attending SCH was carried out for the
2007 (no AR Clinic) and 2010 (established AR Clinic) calendar
years. The year 2010 was chosen for review as it took 2 yearsto fully implement the changes. Written and electronic records
were reviewed for evidence of annual investigations (including
blood tests, lung function testing, and imaging studies) and
multidisciplinary reviews (including medical, dietetic, and phys-
iotherapy reviews) conducted during the 2007 and 2010 calendar
years. All patients diagnosed with CF who regularly attend SCH
for hospital treatment were included in this study. Children born in
the year of the study were excluded as it is our clinic practise to
commence annual review at approximately 12 months of age. A
short informal internet-based satisfaction survey (Appendix 1)
was distributed to families via email to assess their view of the
dedicated AR clinic. Ethics approval was obtained from the local
area health committee (HREC ref. no. LNR/12/SCHN/189).2.4. Statistical analysis
Statistical analysis was performed using SPSS statistical soft-
ware, version 20 (SPSS, Inc., Chicago, IL). Categorical variables
were compared using the chi square test and presented as a
percentage of response. P-values of b0.05 were considered to be
statistically significant.3. Results
One hundred and twenty-three children (mean age 9.5 years,
range 1.32–18.8 years) were eligible for annual review by
continuous assessment in 2007, and 141 children (mean age
8.3 years, range 1.1–18.3 years) were eligible in 2010 for review
at the dedicated AR Clinic.
There was a significant increase in the proportion of patients
who had a documented annual review assessment before and
after the establishment of an AR clinic (28% vs 85%, P b 0.001)
(Table 2). The number of annual review reports generated also
increased significantly (14% vs 85%, P b 0.001). There was a
significant increase in all the annual investigations performed
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(15% vs 70%, P b 0.001) and vitamin A, D and E levels (63% vs
89%, P b 0.001). There was an increase in the proportion of
patients screened for CF complications such as CF related
diabetes through oral glucose tolerance test (OGTT) (2% vs 74%,
P b 0.001) and osteoporosis through bone densitometry (0% vs
81%, P b 0.001). The number of dietetic and physiotherapy
reviews also increased significantly. (Dietary assessment 46% vs
92%, P b 0.001; exercise test 37% vs 84%, P b 0.001; in-
continence screen 27% vs 84%, P b 0.001; inhalation therapy
review 21% vs 87%, P b 0.001).
Of the 141 patients from 131 different families included in the
study from 2010, 110 families (84%) were contacted through
email to complete the satisfaction survey. Fifty-one families
(46%) responded. Overall, 85% of the respondents were satisfied
(34%) or very satisfied (51%) with the annual review process.
Only one person (2%) was very dissatisfied with the process,
13% were neutral. Just over half of the families (51%) felt the
duration of the clinic was just right, 19% felt it was too long, and
6% felt it was too short. Most families (83%) felt the AR report
generated was helpful, 15% were neutral, 2% felt it was
unhelpful. In particular, 44 out of 51 (94%) families felt that the
AR report helped in the management of their child's CF, and that
the report helped expand the parents' (85%) and their children's
(56%) knowledge of CF.Table 2
Annual review capture rates before and after commencement of Annual Review
Clinic.
Annual review or investigation
performed
2007 2010 P value
Performed/
eligible
% Performed/
eligible
%
Documented annual review 34/123 28 120/141 85 b0.001
Annual review report 17/123 14 120/141 85 b0.001
Plethysmography (N8 y.o) 10/68 15 49/70 70 b0.001
Vitamin A, D, E levels 78/123 63 125/141 89 b0.001
Liver function tests 92/123 75 127/139 91 b0.001
Prothrombin time (N5 y.o) 14/94 15 76/96 79 b0.001
Total IgE 58/123 47 126/139 91 b0.001
Aspergillus screen (N5 y.o) 7/94 7 77/96 80 b0.001
OGTT (≥10 y.o) 1/56 2 34/46 74 b0.001
Surveillance BAL (≤5 y.o) 19/29 65 41/45 91 0.01
CXR/Chest CT 53/123 43 119/141 84 b0.001
Abdominal US (N5 y.o) 33/94 35 80/96 83 b0.001
Bone densitometry (≥10 y.o) 0/57 0 34/42 81 b0.001
Dietary assessment (qualitative
or quantitative)
57/123 46 130/141 92 b0.001
Exercise test (N6 yrs) 31/82 37 70/83 84 b0.001
Inhalation therapy review 19/90 21 99/114 87 b0.001
Musculoskeletal exam (N8 yr) 14/68 21 58/70 83 b0.001
Incontinence screen (♀ ≥ 10 yr) 9/33 27 21/25 84 b0.001
IgE— immunoglobulin E.
OGTT— oral glucose tolerance test.
BAL— bronchoalveolar lavage.
CXR— chest X-ray.
US— ultrasound.
NS— not significant.4. Discussions
Our study demonstrates, for the first time, that the AR clinic
significantly increases the number of annual multidisci-
plinary assessment and investigations compared to continuous
assessments.
Previously, Carr and Dinwiddie [5] described the annual
review process and investigation results from 100 children who
underwent formal annual reviews. They also reviewed 20 patients
who did not have annual reviews and found that althoughmost had
spirometry and chest X-ray performed annually, blood tests were
only done in aminority. Hence they suggested that a formal annual
review would allow the CF team to recognise medical problems
such as liver dysfunction and abnormal blood glucose earlier due
to the implementation of regular blood tests in the annual review
process [5]. Long et al demonstrated annual reviews result in more
interventions particularly in the area of physiotherapy and dietetics
compared to routine outpatient visits in the same patients, which is
not surprising as the number of interventions arising from routine
visits depends on clinical grounds [4]. Neither study formally
assessed the changes to the annual review process by having a
dedicated AR clinic compared to continuous assessment.
A major limitation of this study is that we did not assess for,
and hence cannot demonstrate, improvement in clinical outcomes
as a result of the increased investigations and reviews afforded by
the dedicated AR clinic. Previous studies have indicated the
potential benefits of annual investigations. In a study involving
preschool CF children, 11% had management changes as a result
of abnormalities identified from their annual blood tests [7].
Further, our centre previously demonstrated that routine oral
glucose tolerance testing in CF children resulted in early treatment
with insulin and subsequent improvement in lung function and
nutritional status [8,9]. Only through continuous prospective
transparent benchmarking and ongoing clinic data analysis are we
likely to be able to assess the impact of the AR clinic on clinical
outcomes; this approach forms the basis of the quality improve-
ment initiative supported by the Cystic Fibrosis Foundation in the
USA.
An overwhelming majority of the families surveyed were
satisfied or very satisfied with the annual review clinic. One
limitation of the study is the use of a non-validated questionnaire
to assess the families' satisfaction with the clinic or changes in
their knowledge of CF. However, it is recognised that data
collected using non-validated site-specific satisfaction surveys
can be helpful in assessing clinical practise [10]. Although the use
of an internet based survey instrument allowed patient anonymity
and ease of data collection, it did limit the respondents to only
those families who had internet access.
Another limitation of the study is the retrospective nature of
the analysis. Our data analysis was dependent on identifying
annual reviews and investigations from patient records. Therefore,
it is possible, particularly in our 2007 data, that an annual
review was carried out but not formally documented in written
records, leading to a falsely low number of reviews in
2007. However, because we obtained the blood and
radiology investigations from electronic records (and double
checked from paper records), we believe that the increase is a real
189S. Chuang et al. / Journal of Cystic Fibrosis 13 (2014) 186–189effect following the introduction of the dedicated annual review
clinic.5. Conclusion
The introduction of a dedicated AR clinic significantly
increased the number of annual investigations and multidisci-
plinary reviews compared to continuous assessment in children
with CF. It has been well received and is appreciated by the
families we care for. Further data and continual surveillance
are required to determine if the dedicated AR clinic leads to
improved clinical outcomes in CF children.Acknowledgement
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